These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 31515562)

  • 21. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.
    Jakimovski D; Kuhle J; Ramanathan M; Barro C; Tomic D; Hagemeier J; Kropshofer H; Bergsland N; Leppert D; Dwyer MG; Michalak Z; Benedict RHB; Weinstock-Guttman B; Zivadinov R
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1757-1770. PubMed ID: 31437387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice.
    Valentino P; Marnetto F; Martire S; Malucchi S; Bava CI; Popovic M; Bertolotto A
    Mult Scler Relat Disord; 2021 Sep; 54():103090. PubMed ID: 34182224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study.
    Cuello JP; Martínez Ginés ML; Kuhle J; García Domínguez JM; Lozano Ros A; Romero Delgado F; Higueras Y; Meldaña Rivera A; Goicochea Briceño H; García-Tizon Larroca S; De León-Luis J; Michalak Z; Barro C; Álvarez Lafuente R; Medina Heras S; Fernández Velasco JI; Tejeda-Velarde A; Domínguez-Mozo MI; Muriel A; de Andrés C; Villar LM
    Eur J Neurol; 2019 Sep; 26(9):1200-1204. PubMed ID: 30977955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative study.
    Dietmann AS; Kruse N; Stork L; Gloth M; Brück W; Metz I
    J Neurol; 2023 Mar; 270(3):1416-1429. PubMed ID: 36372867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection.
    Traenka C; Disanto G; Seiffge DJ; Gensicke H; Hert L; Grond-Ginsbach C; Peters N; Regeniter A; Kloss M; De Marchis GM; Bonati LH; Lyrer PA; Kuhle J; Engelter ST
    Cerebrovasc Dis; 2015; 40(5-6):222-7. PubMed ID: 26418549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis.
    Rosso M; Gonzalez CT; Healy BC; Saxena S; Paul A; Bjornevik K; Kuhle J; Benkert P; Leppert D; Guttmann C; Bakshi R; Weiner HL; Chitnis T
    Ann Clin Transl Neurol; 2020 Jun; 7(6):945-955. PubMed ID: 32452160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders.
    Liu C; Zhao L; Fan P; Ko H; Au C; Ng A; Au L; Wong A; Kermode AG; Mok V; Yan Y; Qiu W; Lau AY
    J Clin Neurosci; 2021 Jan; 83():108-111. PubMed ID: 33317883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients.
    Valentino P; Malucchi S; Bava CI; Martire S; Capobianco M; Malentacchi M; Sperli F; Oggero A; Di Sapio A; Bertolotto A
    Mult Scler Relat Disord; 2023 Sep; 77():104893. PubMed ID: 37481820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple Sclerosis.
    Huppke B; Reinert MC; Hummel-Abmeier H; Stark W; Gärtner J; Huppke P
    Neurology; 2023 Nov; 101(19):e1873-e1883. PubMed ID: 37748882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis.
    Loonstra FC; de Ruiter LRJ; Koel-Simmelink MJA; Schoonheim MM; Strijbis EMM; Moraal B; Barkhof F; Uitdehaag BMJ; Teunissen C; Killestein J
    Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36543540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.
    Onatsu J; Vanninen R; Jäkälä P; Mustonen P; Pulkki K; Korhonen M; Hedman M; Zetterberg H; Blennow K; Höglund K; Herukka SK; Taina M
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2242-2249. PubMed ID: 31151840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study.
    Meyer T; Dreger M; Grehl T; Weyen U; Kettemann D; Weydt P; Günther R; Lingor P; Petri S; Koch JC; Großkreutz J; Rödiger A; Baum P; Hermann A; Prudlo J; Boentert M; Weishaupt JH; Löscher WN; Dorst J; Koc Y; Bernsen S; Cordts I; Vidovic M; Steinbach R; Metelmann M; Kleinveld VE; Norden J; Ludolph A; Walter B; Schumann P; Münch C; Körtvélyessy P; Maier A
    Eur J Neurol; 2024 Sep; 31(9):e16379. PubMed ID: 38859579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS.
    Aktas O; Renner A; Huss A; Filser M; Baetge S; Stute N; Gasis M; Lepka K; Goebels N; Senel M; Graf J; Enzinger C; Pinter D; Antoch G; Turowski B; Hartung HP; Albrecht P; Otto M; Tumani H; Penner IK
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32972970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
    Buchmann A; Pirpamer L; Pinter D; Voortman M; Helmlinger B; Pichler A; Maceski AM; Benkert P; Bachmaier G; Ropele S; Reindl M; Leppert D; Kuhle J; Enzinger C; Khalil M
    Eur J Neurol; 2023 May; 30(5):1389-1399. PubMed ID: 36779855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
    Grut V; Biström M; Salzer J; Stridh P; Jons D; Gustafsson R; Fogdell-Hahn A; Huang J; Butt J; Lindam A; Alonso-Magdalena L; Bergström T; Kockum I; Waterboer T; Olsson T; Zetterberg H; Blennow K; Andersen O; Nilsson S; Sundström P
    Brain; 2024 Jan; 147(1):177-185. PubMed ID: 37930324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients.
    Hänninen K; Jääskeläinen O; Herukka SK; Soilu-Hänninen M
    Brain Behav; 2020 Sep; 10(9):e01772. PubMed ID: 32705821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis.
    Bsteh G; Berek K; Hegen H; Teuchner B; Buchmann A; Voortman MM; Auer M; Wurth S; Zinganell A; Di Pauli F; Deisenhammer F; Khalil M; Berger T
    Mult Scler; 2020 Nov; 26(13):1682-1690. PubMed ID: 31668116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis.
    Rosso M; Healy BC; Saxena S; Paul A; Bjornevik K; Kuhle J; Benkert P; Leppert D; Guttmann C; Bakshi R; Weiner HL; Chitnis T
    J Neuroimaging; 2021 Mar; 31(2):388-393. PubMed ID: 33476489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis.
    Jons D; Zetterberg H; Biström M; Alonso-Magdalena L; Gunnarsson M; Vrethem M; Blennow K; Nilsson S; Sundström P; Andersen O
    Ann Clin Transl Neurol; 2022 Jun; 9(6):882-887. PubMed ID: 35502756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.